The arthritis studies in this clinic were made possible by a grant from the Commonwealth Fund, New York City ... the Department of Medicine, Harvard Medical School, and the Massachusetts ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

This new study not only clarifies the causes of gout but also helps scientists explore more treatment options. Existing drugs ...

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...

EULAR 2024 New Gout Drugs Might Increase Patients ... Not Symptoms Basing the treatment of gout on reaching and maintaining target serum uric acid level is already endorsed in guidelines, but ...

The findings open up new avenues for research into gout prevention and treatment, and the genetic risk score could be a powerful tool for identifying at-risk individuals. The study also ...

Dual-energy computed tomography (CT) is a relatively new approach to gout diagnosis ... the patient responded to gout treatment. Three patients had calcium pyrophosphate crystals in joint fluid ...

After one to two weeks, the inflammation eventually goes away on its own. If you have gout, talk to your doctor about medications and lifestyle changes that can help.